An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.
Investigational Drug Gaining Traction Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of members share comparison images, administration instructions and claims of next-day British shipping. Vendors promote the substance there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.
Some professionals said the popularity for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, marketing, and customer laws, risking fines, prosecution or prison.
Service Reaction and Material Removal
According to TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.
Online Trading Operations
Investigations also discovered communities with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of slimming results, glowing testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of entering one group, a vendor posted contact information, where most transactions take place. The seller sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Product Details and Costs
Inside these communities, posts display black plastic packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how much time a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram stated it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to potentially serious medical dangers”.
